publication venue for
- Decrypting biological hallmarks of aging in people with HIV. 2023
- Antiretroviral therapy and cardiovascular risk: are some medications cardioprotective?. 3. 2008
- Treatment interruption in chronic HIV-1 infection: does it deliver?. 2. 2007
- Editorial: On two fronts: synergies and costs at the interface of responses to two global viral pandemics.. 16. 2021
- New HIV drugs: 2018 and beyond.. 13. 2018
- Roles of fragment crystallizable-mediated effector functions in broadly neutralizing antibody activity against HIV. 2020
- Broadly neutralizing antibodies for the treatment and prevention of HIV infection. 2020
- HIV treatment and prevention 2019: current standards of care. 2020
- Presentation of HIV-1 envelope glycoprotein trimers on diverse nanoparticle platforms. 2019
- Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection. 2018
- Youth-friendly services and differentiated models of care are needed to improve outcomes for young people living with HIV. 2018
- Lessons learned from human HIV vaccine trials. 2017
- Hepatocellular carcinoma in patients with HIV. 2017
- Strategies to target non-T-cell HIV reservoirs. 2016
- Mother and child both matter: reconceptualizing the prevention of mother-to-child transmission care continuum. 2015
- Injectable agents for pre-exposure prophylaxis: lessons learned from contraception to inform HIV prevention. 2015
- Antibodies for prevention of mother-to-child transmission of HIV-1. 2015
- Broadly neutralizing antibody and the HIV reservoir in acute HIV infection: a strategy toward HIV remission? 2015
- The emerging face of the HIV epidemic in the Middle East and North Africa. 2014
- Cost-effectiveness of pre-exposure prophylaxis for HIV: a review. 2012
- Next-generation oral preexposure prophylaxis: beyond tenofovir. 2012
- A pièce de resistance: how HIV-1 escapes small molecule CCR5 inhibitors. 2009